Pheton Holdings Ltd (NASDAQ:PTHL) Sees Large Decline in Short Interest

Pheton Holdings Ltd (NASDAQ:PTHL) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totaling 17,067 shares, a decrease of 29.4% from the December 15th total of 24,161 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average trading volume of 68,493 shares, the days-to-cover ratio is currently 0.2 days. Based on an average trading volume of 68,493 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.3% of the company’s stock are short sold.

Analysts Set New Price Targets

A number of research firms have commented on PTHL. Weiss Ratings reissued a “sell (e+)” rating on shares of Pheton in a report on Friday, October 31st. Wall Street Zen upgraded Pheton from a “sell” rating to a “hold” rating in a report on Sunday, September 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Pheton presently has a consensus rating of “Sell”.

Pheton Price Performance

PTHL traded down $0.29 during mid-day trading on Monday, reaching $0.61. 1,802,629 shares of the company traded hands, compared to its average volume of 3,792,516. The company’s fifty day moving average price is $0.54 and its 200-day moving average price is $3.43. Pheton has a 52-week low of $0.39 and a 52-week high of $32.00.

Pheton Company Profile

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.